
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | -- | -- | -- | $1.60 | -- |
07/30/2025 | Q2 | -- | -- | -- | $1.60 | -- |
04/30/2025 | Q1 | -- | $26.4M | $1.58 | $1.48 | $0.11 |
01/30/2025 | Q4 | -- | $26.2M | $1.66 | $1.52 | $0.14 |
10/30/2024 | Q3 | -- | $25.1M | $1.57 | $1.37 | $0.21 |
07/30/2024 | Q2 | -- | $24.6M | $1.10 | $1.30 | -$0.20 |
04/25/2024 | Q1 | $22.2M | $24.8M | $1.47 | $1.52 | -$0.05 |
01/30/2024 | Q4 | $22.7M | $25.3M | $1.57 | $1.59 | -$0.02 |
10/23/2023 | Q3 | $21.7M | $26.1M | $1.57 | $1.54 | $0.04 |
07/31/2023 | Q2 | $18.4M | $20.2M | -$1.00 | -$0.02 | -$0.98 |
04/27/2023 | Q1 | $19.3M | $20.3M | $1.69 | $1.80 | -$0.10 |
01/30/2023 | Q4 | -- | $21.6M | $1.93 | -- | -- |
10/24/2022 | Q3 | -- | $21.5M | $1.82 | -- | -- |
07/21/2022 | Q2 | -- | $20M | $1.69 | -- | -- |
05/09/2022 | Q1 | -- | $18.7M | $1.64 | -- | -- |
12/31/2021 | Q4 | -- | $19.4M | $1.69 | -- | -- |
09/30/2021 | Q3 | -- | $19.4M | $1.72 | -- | -- |
06/30/2021 | Q2 | -- | $18.9M | $1.62 | -- | -- |
03/31/2021 | Q1 | -- | $20.7M | $2.06 | -- | -- |
12/31/2020 | Q4 | -- | $20.5M | $1.76 | -- | -- |
09/30/2020 | Q3 | -- | $20M | $1.94 | -- | -- |
06/30/2020 | Q2 | -- | $18.4M | $1.29 | -- | -- |
03/31/2020 | Q1 | -- | $14.7M | $1.22 | -- | -- |
12/31/2019 | Q4 | -- | $14.9M | $1.35 | -- | -- |
09/30/2019 | Q3 | -- | $15.1M | $1.39 | -- | -- |
06/30/2019 | Q2 | -- | $14.4M | $1.29 | -- | -- |
03/31/2019 | Q1 | -- | $13.9M | $1.18 | -- | -- |
12/31/2018 | Q4 | -- | $14.2M | $1.20 | -- | -- |
09/30/2018 | Q3 | -- | $13.8M | $1.22 | -- | -- |
06/30/2018 | Q2 | -- | $13.6M | $1.24 | -- | -- |
03/31/2018 | Q1 | -- | $13.3M | $1.13 | -- | -- |
12/31/2017 | Q4 | -- | $14M | $0.69 | -- | -- |
09/30/2017 | Q3 | -- | $12.5M | $0.97 | -- | -- |
06/30/2017 | Q2 | -- | $12.3M | $0.92 | -- | -- |
03/31/2017 | Q1 | -- | $12M | $0.87 | -- | -- |
12/31/2016 | Q4 | -- | $12M | $0.84 | -- | -- |
09/30/2016 | Q3 | -- | $11.6M | $0.83 | -- | -- |
06/30/2016 | Q2 | -- | $11.2M | $0.79 | -- | -- |
03/31/2016 | Q1 | -- | $11.1M | $0.86 | -- | -- |
12/31/2015 | Q4 | -- | $9.9M | $0.70 | -- | -- |
09/30/2015 | Q3 | -- | $9.5M | $0.83 | -- | -- |
Citizens Financial Services reported $26.4M worth of top line sales in its most recent quarter.
Citizens Financial Services announced earnings per share of $1.58 which represents a beat of analyst forecast a $1.48 per share.
Citizens Financial Services reported -- that represents -- per share over the last quarter.
Citizens Financial Services's earnings are forecast to grow from $5.79 per share to $5.45 per share next year representing an increase of 11.8%.
Citizens Financial Services's next earnings date is July 30, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.